Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Linear ubiquitin assembly complex regulates lung epithelial–driven responses during influenza infection
Patricia L. Brazee, … , Laura A. Dada, Jacob I. Sznajder
Patricia L. Brazee, … , Laura A. Dada, Jacob I. Sznajder
Published November 12, 2019
Citation Information: J Clin Invest. 2020;130(3):1301-1314. https://doi.org/10.1172/JCI128368.
View: Text | PDF
Research Article Inflammation Pulmonology

Linear ubiquitin assembly complex regulates lung epithelial–driven responses during influenza infection

  • Text
  • PDF
Abstract

Influenza A virus (IAV) is among the most common causes of pneumonia-related death worldwide. Pulmonary epithelial cells are the primary target for viral infection and replication and respond by releasing inflammatory mediators that recruit immune cells to mount the host response. Severe lung injury and death during IAV infection result from an exuberant host inflammatory response. The linear ubiquitin assembly complex (LUBAC), composed of SHARPIN, HOIL-1L, and HOIP, is a critical regulator of NF-κB–dependent inflammation. Using mice with lung epithelial–specific deletions of HOIL-1L or HOIP in a model of IAV infection, we provided evidence that, while a reduction in the inflammatory response was beneficial, ablation of the LUBAC-dependent lung epithelial–driven response worsened lung injury and increased mortality. Moreover, we described a mechanism for the upregulation of HOIL-1L in infected and noninfected cells triggered by the activation of type I IFN receptor and mediated by IRF1, which was maladaptive and contributed to hyperinflammation. Thus, we propose that lung epithelial LUBAC acts as a molecular rheostat that could be selectively targeted to modulate the immune response in patients with severe IAV-induced pneumonia.

Authors

Patricia L. Brazee, Luisa Morales-Nebreda, Natalia D. Magnani, Joe G.N. Garcia, Alexander V. Misharin, Karen M. Ridge, G.R. Scott Budinger, Kazuhiro Iwai, Laura A. Dada, Jacob I. Sznajder

×

Figure 6

Loss of HOIP from the alveolar epithelium inhibits alveolar epithelial-driven inflammatory response to IAV infection.

Options: View larger image (or click on image) Download as PowerPoint
Loss of HOIP from the alveolar epithelium inhibits alveolar epithelial-d...
(A–G) WT and SPCCre/HOIPfl/fl mice were infected with a lethal dose of WSN. (A–C) AT2 cells at 0 and 4 d.p.i. (n = 9) analyzed for Il6 mRNA (A), Ifnb mRNA (B), and Mcp1 mRNA (C). (D–F) BALF analyzed by ELISA at 0, 3, 5, and 7 d.p.i. (n = 9) for IL-6 (D), MCP-1 (E), and IFN-β (F). (G–I) Lung immune cell populations at 0, 5, and 7 (n = 9) d.p.i. analyzed by flow cytometry for Ly6G+CD11b+CD24+ neutrophils (G), NK1.1+CD11bhiCD24hi natural killer cells (H), and CD44+CD62L–CD8+ T cells (I). Means ± SD overlaid with individual data points representing replicates are depicted; *P < 0.05, **P < 0.01, ****P < 0.0001 (1-way ANOVA, Bonferroni post hoc test).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts